TY - GEN

AU - Eyler, Patricia

TI - Bevacizumab Reexposition in der Therapie des rezidivierenden Ovarialkarzinoms

PB - Universität Ulm

KW - Eierstockkrebs

KW - Krebs

KW - Gynäkologische Onkologie

KW - Therapie

KW - Rezidiv

KW - Bevacizumab

KW - Deutschland

KW - Ovarialkarzinom

KW - Reexposition Bevacizumab

KW - Ovarialkarzinom Rezidiv

KW - (MESH)Ovarian neoplasms; Drug therapy

KW - (MESH)Antibodies, Monoclonal, Humanized; Therapeutic use

KW - (MESH)Neoplasm recurrence, Local; Drug therapy

PY - 2022

CY - Ulm

UR - http://slubdd.de/katalog?TN_libero_mab2

ER -